Tag: Hatch-Waxman Act

Why the First Generic Filer Gets 180 Days of Market Exclusivity

The first generic filer gets 180 days of market exclusivity to encourage patent challenges that lower drug prices. But this system is being exploited-delaying competition and hurting patients.

Read More

Antitrust Laws and Competition Issues in Generic Pharmaceutical Markets

Antitrust laws in the generic drug market aim to prevent companies from blocking cheaper alternatives through pay-for-delay deals, patent manipulation, and product hopping. These tactics cost patients billions and limit access to essential medicines.

Read More